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Introduction: There is no clear consensus as to what constitutes an obstructive ventilatory defect (OVD): Is it
FEV1/FVCBlower limit of normal (LLN) orB0.70 (respectively, physiological and operational definitions)?
Aim: To determine, according to the two definitions, the percentage of subjects having an OVD among them
explored in a lung function exploration laboratory.
Population and methods: This is a retrospective study including 4,730 subjects aged 1785 years. Subjects were
divided according to the presence [physio () or operat ()] or absence [physio () or operat ()] of an OVD,
and into younger (B45 years, n2,076), older (]45 years, n2,654), smokers (n1,208), and non-smokers
(n3,522) groups.
Results: For the total sample, the younger and older groups [mean9SD of age (years), respectively, 46.7914.1;
33.997.4, and 56.899.1], the ‘physiological definition’ detected, respectively, 13.46, 43.22, and 5.09% more
OVD than the ‘operational one’ (pB0.05). In addition, the operational definition, compared with the physio-
logical one, overdiagnosed OVD in 2.33 and 0.44% of smokers and non-smokers, respectively, and under-
diagnosed it in 4.46% and 29.72% of smokers and non-smokers, respectively (pB0.05). Compared with
the group ‘physio (), operat ()’, the ‘physio (), operat ()’ one was younger (74.294.7 years vs.
40.9910.3 years) and had significantly higher FEV1 (62913% vs. 78917%) and FVC (71915% vs. 93919%).
Conclusion: The frequency of OVD much depends on the criteria used for its definition.
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T
he prevalence of bronchial asthma and chronic
obstructive pulmonary disease (COPD) is constantly
increasing worldwide including African countries
(1, 2). These two chronic diseases, often having in com-
mon an obstructive ventilatory defect (OVD), should
be diagnosed more accurately by using spirometry (3, 4).
However, there is no clear consensus as to what constitutes
an OVD.
On the one hand, the American Thoracic Society (ATS)
and the European Respiratory Society (ERS) (5) opted for
a ‘physiological definition’ based on a first-second forced
expiratory volume/forced vital capacity (FEV1/FVC) ratio
below the lower limit of normal (LLN) range. On the other
hand, the Global Initiative for Chronic Obstructive Lung
Disease (GOLD) opted for an ‘operational definition’ based
on a fixed threshold value of 0.70 (FEV1/FVCB0.70) (3).
The last definition was recently criticised in an open
letter addressed to GOLD committee members (610).
The main criticism was that the FEV1/FVC ratio declines
with increasing age and height, even in healthy lifelong
non-smokers, whose LLN drops below a ratio of 0.70 from
about 45 years of age (610). Therefore, the use of a fixed
threshold value causes up to 50% overdiagnosis (misclas-
sification) above that age (610). Authors and signatories
of the open letter have asked GOLD committee members
to abandon the ‘operational method’ in favour of the
‘physiological’ one (610).
The lack of a clear worldwide consensus about OVD
definition could be a source of confusion and/or mis-
diagnosis for clinicians and respiratory researchers. This
is the case in Africa, where the ‘operational definition’
is widely applied (1115). For example, a recent paper
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published in the Libyan Journal of Medicine (11) was criti-
cised (16) since authors have opted for the use of a fixed
threshold of 0.70 to define the OVD.
Recently, the ATS/ERS in a paper entitled ‘Research
Questions in COPD’ have recommended studies that
evaluate the impact of age on the importance of identify-
ing an OVD (17). Thus, the aim of the present study is to
highlight, on a large sample, the potential errors engen-




It is a retrospective study including anthropometric and
spirometric data (n4,516 records) from a local team’s pre-
vious published studies during the last 10 years (1834).
Some included data (n214 cases) were prospectively
evaluated during January and February of 2015.
The Tunisian population comprises people of mainly
Arab, Berber, and Turkish descent (26).
Inclusion and non-inclusion criteria
Only reproducible spirometric data of subjects aged more
than 17 years were considered for analysis.
Collected data
Quantity of used cigarettes and/or narghile [respectively, in
packets-years (PY) and narghiles-years (NY)], age (years),
height (m), weight (kg), body mass index (BMI, kg/m2),
FEV1 (L,%), FVC (L,%), and FEV1/FVC (absolute value).
Smoking status (smoker/non-smoker)
The subject was qualified as a smoker when the cigarette
or narghile use was ]5 PY or NY, respectively, or when
the sum of cigarette and narghile use was ]5 (20, 26).
Spirometric measurements
All spirometric measurements were performed according
to the ATS/ERS 2005 guidelines (3537). Local spirometric
norms were applied (20, 26, 38).
Applied definitions
Subjects were divided into seven groups of 10-year age
ranges, into two groups of younger (B45 years) or older
(]45 years) subjects (610, 39), and into two groups of
smokers and non-smokers. According to the presence or
absence of an OVD, subjects were divided into six groups:
Group I: Physiological definition ‘physio ()’: FEV1/
FVCBLLN.
Group II: Operational definition ‘operat ()’: FEV1/
FVCB0.7.
Group III: ‘physio (), operat ()’: FEV1/FVCBLLN
and FEV1/FVC]0.70.
Group IV: ‘operat (), physio ()’: FEV1/FVCB0.70
and FEV1/FVC]LLN.
Group V: ‘physio (), operat ()’: FEV1/FVCBLLN
and FEV1/FVCB0.70.
Group VI: ‘physio (), operat ()’: FEV1/FVC]LLN
and FEV1/FVC ]0.70.
Statistical analyses
Quantitative and qualitative data were expressed, respec-
tively, as mean9SD and as number (%). Chi-square test was
used to compare percentages of included subjects between
Groups I and II. Parametric (t-test) and non-parametric
(MannWhitney U) tests were used to compare anthropo-
metric and spirometric data between Groups III and VI.
Analyses were carried out using Statistica statistical software
(Statistica Kernel version 6; Stat Software, Maisons-Alfort,
France). Significance was set at the 0.05 level.
Results
Anthropometric and spirometric data of 4,730 subjects
were retained. Table 1 presents their data divided accord-
ing to age ranges. Compared with the ‘physio ()’ group,
the ‘operat ()’ group included significantly lower per-
centages of subjects (total samples data) only in age ranges
B55 years. For the total sample (1785 years), compared
with the ‘physiological definition’, the ‘operational defini-
tion’ gives a significantly lower percentage of subjects
having OVD, respectively, 19.15% vs. 16.57%. Thus, the
‘physiological definition’ detected 13.46% more OVD than
the ‘operational definition’.
For both younger (n2,076) and older (n2,654) groups
[mean9SD of age (years): 33.997.4 and 56.899.1, res-
pectively], compared with the ‘physiological definition’,
the ‘operational definition’ gives statistically significant
lower percentages of subjects having OVD, respectively,
9.59% vs. 5.44% and 26.64% vs. 25.28%. Thus, the ‘physio-
logical definition’ detected 43.22 and 5.09% more OVD
than the ‘operational definition’, respectively, in younger
and older groups.
Table 2 presents the anthropometric and spirometric
data of included subjects divided according to OVD defi-
nitions (Groups IIIVI). Compared with the ‘operat (),
physio ()’ group, the ‘physio (), operat ()’ group
was younger, had significantly higher FEV1 and FVC, and
included higher percentages of females and non-smokers.
Among the 784 subjects ‘operat ()’ (Table 1), 14 (2%)
were ‘physiol ()’ (Table 2). Among the 906 subjects
‘physio ()’ (Table 1), 136 (15%) were ‘operat ()’ (Table 2).
Figure 1 shows the step-by-step distribution of in-
cluded subjects with respect to OVD definitions [operat
‘’ (Fig. 1a); operat ‘’ (Fig. 1b)] and smoking status.
Depending on the OVD definitions and smoking status,
each subgroup was distinguished in different cells (A1A2;
B1B4). The analysis of Fig. 1 revealed the following:
1. Among the 557 smokers ‘operat ()’ [B1B3
(Fig. 1a)], 13 were ‘physiol ()’ [B3 (Fig. 1a)], and
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Table 1. Anthropometric and spirometric data of included subjects divided according to age ranges (n4,730)
Anthropometric data FEV1 FVC FEV1/FVC
Age
range









M (n189) 21.592.1 1.7590.07 71912 23.293.3 4.2790.53 89910 4.9790.65 90910 0.8690.05 0 (0.00) 6 (3.19)* 0.0169
1725 F (n111) 21.091.9 1.6590.08 61910 22.693.6 3.4090.60 90912 3.8690.67 88911 0.8890.05 0 (0.00) 0 (0.00) 1
T (n300) 21.392.0 1.7190.09 68912 23.093.4 3.9590.70 90911 4.5690.85 89910 0.8690.05 0 (0.00) 6 (2.00)* 0.0141
M (n556) 30.092.8 1.7490.07 78914 25.694.0 4.0090.62 88911 4.8590.77 92911 0.8290.06 17 (3.05) 47 (8.45)* 0.003
2535 F (n182) 30.592.9 1.6590.08 68912 25.294.0 3.3090.91 94917 3.9190.91 95917 0.8490.05 3 (1.64) 8 (4.39) 0.2641
T (n738) 30.192.8 1.7290.08 75914 25.594.0 3.8290.71 90913 4.6290.90 93913 0.8390.06 20 (2.71) 55 (7.45)* 0.003
M (n768) 40.192.7 1.7190.07 80914 27.294.3 3.5190.69 84915 4.3790.77 90913 0.8090.07 84 (10.93) 118 (15.36)* 0.0199
3545 F (n270) 39.892.7 1.6290.08 73912 27.894.3 3.0090.71 94919 3.6190.85 95918 0.8390.06 9 (3.33) 20 (7.40)* 0.0334
T (n1038) 40.192.7 1.6990.09 78914 27.494.3 3.3890.73 86916 4.1790.86 91915 0.8190.07 93 (8.58) 138 (13.29)* 0.036
M (n870) 49.692.8 1.7190.06 78914 26.694.5 2.9390.88 75921 3.8390.83 84916 0.7590.13 197 (22.64) 229 (26.32) 0.1459
4555 F (n484) 49.593.0 1.5990.08 73911 28.794.2 2.5790.61 89917 3.1190.75 91917 0.8290.06 12 (2.47) 20 (4.13) 0.0685
T (n1354) 49.692.8 1.6790.09 76913 27.494.5 2.8090.81 80921 3.5890.88 86917 0.7790.11 209 (15.43) 249 (18.38)* 0.0356
M (n458) 58.792.7 1.6890.07 75914 26.794.7 2.4490.87 67923 3.3090.84 78918 0.7290.14 157 (34.27) 162 (35.37) 0.7503
5565 F (n256) 58.892.8 1.5890.08 71912 28.294.5 2.2690.61 87919 2.7490.72 88918 0.8290.09 16 (6.25) 19 (7.42) 0.6465
T (n714) 58.792.7 1.6590.09 74914 27.294.7 2.3890.79 74923 3.1090.84 82918 0.7690.14 173 (24.22) 181 (25.35) 0.6605
M (n328) 68.592.6 1.6790.07 71912 25.594.4 1.7190.78 54925 2.5990.84 67921 0.6490.14 197 (60.06) 190 (57.92) 0.6027
6575 F (n104) 68.192.3 1.5690.09 65911 26.993.9 1.9990.71 87924 2.4490.80 89921 0.8190.10 9 (8.65) 9 (8.65) 1
T (n432) 68.492.6 1.6490.09 69912 25.894.4 1.7890.77 62928 2.5590.83 73923 0.6890.15 206 (47.68) 199 (46.06) 0.5561
M (n129) 77.992.7 1.6490.06 69910 25.593.8 1.4790.63 62917 2.3090.56 72918 0.6290.17 83 (64.34) 78 (60.46) 0.5087
7585 F (n25) 78.492.3 1.4890.04 6297 28.392.9 1.3890.23 80914 1.5890.28 74915 0.8790.05 0 (0.00) 0 (0.00) 1
T (n154) 78.092.7 1.6290.08 6899 25.993.8 1.4690.58 64927 2.1890.59 66918 0.6690.18 83 (53.89) 78 (50.64) 0.5985
M (n3298) 46.7914.4 1.7190.07 76914 26.294.4 3.0791.09 76922 3.9491.10 84917 0.7690.12 735 (22.28) 830 (25.16)* 0.0041
1785 F (n1432) 46.6913.4 1.6090.08 70912 27.494.5 2.6990.79 90918 3.2390.93 91918 0.8390.07 49 (3.42) 76 (5.30)* 0.0064
T (n4730) 46.7914.1 1.6790.09 75914 26.694.5 2.9691.02 90922 3.7291.10 86918 0.7890.12 784 (16.57) 906 (19.15)* 0.0114
BMI, body mass index in kg/m2; F, Female; FEV1, first-second forced expiratory volume; FVC, forced vital capacity; LLN, lower limit of normal; M, male; T, total sample. Quantitative data are



































































































among the 227 non-smokers ‘operat ()’ [B2B4
(Fig. 1a)], only one was ‘physiol ()’ (B4 (Fig. 1a)).
Thus, the ‘operational definition’ overdiagnosed OVD
in 2.33% of smokers and in 0.44% of non-smokers.
2. Among the 583 smokers ‘physiol ()’ [B1 (Fig. 1a)
B1 (Fig. 1b)], 26 were ‘operat ()’ [(B1 (Fig.1a)B1
(Fig.1b))  (B1B3 (Fig.1a))], and among the
323 non-smokers ‘physiol ()’ [B2 (Fig. 1a)B2
(Fig. 1b)], 96 were ‘operat ()’ [(B2 (Fig. 1a)B2
(Fig. 1b))  (B2B4 (Fig. 1a))]. Thus, the ‘opera-
tional definition’ underdiagnosed OVD in 4.46% of
smokers and in 29.72% of non-smokers.
Discussion
The present study, involving 4,730 adults, shows that the
percentage of subjects having an OVD is recommendation
dependent, especially in the age ranges B55 years. For the
total sample (1785 years), the younger (B45 years) and
the older (]45 years) groups, the ‘physiological defini-
tion’ detected, respectively, 13.46, 43,22, and 5.09% more
OVD than the ‘operational definition’. In addition, the
‘operational definition’, compared with the ‘physiological
definition’, overdiagnosed OVD in 2.33 and 0.44% of
smokers and non-smokers, respectively, and underdiagnosed
it in 4.46% and 29.72% of smokers and non-smokers,
respectively. Therefore, a subject could be diagnosed as
having or not having an OVD depending on which
definition was applied.
Brief history of OVD spirometric definitions
In 1983, the ERS defined OVD as FEV1/FVCB88
andB89% of its predicted value, respectively, in males
and females (40). In 1991, the ATS defined it as FEV1/
FVCBLLN (41). In 1994, BTS opted for the use of a
fixed threshold (FEV1/FVCB0.70 and FEV1B80% of its
predicted value) (42). In 2000, Viegi et al. (43) defined it
as an FEV1/FVCB0.70. In 2001, GOLD adopted the
BTS definition (44). In 2005, the ATS/ERS opted for the
‘physiological definition’ using the LLN concept (5), but
slow vital capacity replaced FVC. In 2012, a new definition
(FEV1/FVCBz-score) was proposed by the Global Lung
Initiative (GLI) (45). All these definitions continue to be
used around the world; hence, a worldwide clear consensus
is needed (17, 39).
Table 3 displays results of some studies (4651) with a
similar aim to the present one.
Discussion of the methodology
Study design
Like some other studies having similar aims (46, 4954),
the present one was retrospective. It was better to opt for
Table 2. Anthropometric and spirometric data of included subjects divided according to OVD definitions (n4,730)
Group III ‘physio (),
operat ()’
Group IV ‘physio (),
operat ()’
Group V ‘physio (),
operat ()’














Sex Male 109 (80) 14 (100)* 721 (94) 2,454 (64)*
Female 27 (20) 0 (0)* 49 (16) 1,356 (36)*
Smoking status Smoker 39 (29) 13 (93)* 544 (71) 544 (14)*
Non-smoker 97 (71) 1 (7)* 226 (29) 3,266 (86)*
Age (year) 40.9910.3 74.294.7a 57.8911.9 44.5913.4b
Height (m) 1.7190.09 1.6790.02a 1.6990.07 1.6790.09b
Weight (kg) 79916 7596 70914 75914b
BMI (kg/m2) 26.894.6 26.792.0 24.894.6 27.094.4b
FEV1 (L) 3.1390.78 1.6890.33
a 1.7390.84 3.2190.87b
(%) 78917 62913a 48920 87916b
FVC (L) 4.3791.07 2.4990.49a 2.9991.10 3.8591.04b




0.7190.01 0.6790.00a 0.5690.10 0.8390.05b
BMI, body mass index; FEV1, first-second forced expiratory volume; FVC, forced vital capacity; OVD, obstructive ventilatory defect;
LLN, lower limit of normal. Data are mean9SD, except for sex and smoking status, where data are number (%). aProbability
(MannWhitney U test)B0.05: Group III vs. Group IV. bProbability (t-test)B0.05: Group V vs. Group VI. *Probability (chi-square) B0.05:
Group III vs. Group IV or Group V vs. Group VI.
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a prospective study as done by some authors (47, 48).
However, such studies require more time and human and
economic resources (55, 56). In the present study, 5% of
data were prospectively evaluated. In this prospective
subgroup (n214), similar results were found [statisti-
cally significant difference between the percentage of
subjects with an OVD according to the ‘physiological’
30.4% vs. the ‘operational’ (22.9%) definitions]. It was
better to collect subjects’ medical data especially those
about COPD and/or asthma (47, 48, 53). However, it
seems that the diagnosis of COPD is also recommenda-
tion dependent, as shown in a recent local study (21).
Fig. 1. Distribution of included subjects with respect to obstructive ventilatory defect definitions and smoking status:
(a) operational definition ‘negative’; (b) operational definition ‘positive’.
FEV1, first-second forced expiratory volume; FVC, forced vital capacity; LLN, lower limit of normal; n, number; %: percentage
of smokers with OVD; FEV1/FVC LLN values are mean9SD.
How to define obstructive ventilatory defect?
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Table 3. Results of some studies aiming to compare the OVD operational and physiological definitions
First author Miller (49) Lau (48) Szanto (51) Roberts (50) Aggarwal (46) Present study




Hong Kong Sweden USA India Tunisia
Study design Retrospective Prospective Retrospective Retrospective Retrospective Retrospective/partially
prospective

























History of pleurodesis or chest tube insertion
or thoracic surgery
Acute illness (past 3 months)






Age515 years Lack of cooperation
Applied spirometric guidelines ATS/ERS 2005
(35)














Local norms (70) Local norms (20, 26, 38)
Age ranges (years) 2092 2080 6093 1495 1595 1785
Percentages of subjects with
an OVD
Operational definition 38 19 23 40 37 17
Physiological definition 32 14 10 37 (69) to 43 (74) 33 19
Significant difference between
definitions
Yes Yes Yes No Yes Yes






















































































As carried out in some studies (46, 4850), the present one
included samples with a large age range (1785 years).
Szanto et al. (51) have opted for an elderly group aged
]60 years. It is interesting to perform similar studies in
children and adolescents who also need a clear consensus
concerning OVD definition (45).
Discussion of the results
In the present study, the ‘physiological definition’ detected
significantly 13.46% more OVD than the ‘operational
definition’ (Table 1). On the one hand, this result was
contrary to what was previously published, where the
‘physiological definition’ compared with the ‘operational
definition’ significantly underdiagnosed OVD by 4% (46),
5% (48), and 6% (49) (Table 3). On the other hand, the
present result was intermediate to the one published
by Roberts et al. (50), where the differences between the
two definitions were about 3 to 3%, depending on the
applied spirometric norms. It is important to note that
the differences reported by Roberts et al. (50) were not
statistically significant (Table 3). The present study result
cannot be compared with the one of Szanto et al. (51)
(reporting a difference of 13% in favour of the ‘opera-
tional definition’) since they have studied only elderly
subjects (Table 3). Some plausible explanations of the
results’ divergence could be study design [retrospective vs.
prospective (55, 56)], sample size (57) [low, e.g.,B2,000
(48, 50, 51) vs. high, e.g.,4,000 (46, 49)], applied in-
clusion and exclusion criteria (5860) [e.g. comorbidities
(48)], applied spirometric guidelines [old (46, 48, 50, 51)
(ATS-1995 (61)) vs. new (46, 49) (ATS/ERS-2005 (35)],
and age ranges [large (46, 4850) vs. narrow (51)].
The following sections will discuss the advantages and
disadvantages of the two most applied definitions to
diagnose OVD.
Operational definition
The advantage of the ‘operational definition’ (3) is that
the diagnosis of OVD is made by reference to one easy
to remember number (0.70), avoiding the use of reference
values and calculations (43). Its use by general practi-
tioners or specialists of other disciplines could be justified
by its simplicity (43). These qualities lend it to practical use
in the detection of COPD in any country (31). In addition,
the use of the ‘operational definition’ is associated with
increased death risk, whereas using the ‘physiological defi-
nition’ is not (71). The profile of subjects ‘operat (),
physio ()’ is characterised by the predominance of males
and smokers; the advanced age of included subjects; and
lower FEV1, FVC, and FEV1/FVC (Group IV, Table 2).
However, the ‘operational definition’, the main objec-
tive of which is to favour screening, has its limits. First, the
argument that the fixed cut-off of 0.70 is easy to remember
cannot be justified because even inexpensive pocket spiro-
meters compute the predicted FEV1 and FEV1/FVC,
as well as the LLN (72). Secondly, ignoring that FEV1/
FVC ratio changes with age (38, 50, 73) probably leads
to and underestimates the OVD prevalence in the young
subjects and overestimates its prevalence in the elderly
subjects (74, 75). Thirdly, the fixed ratio does not delimit
mild airways obstruction and its use introduces an im-
portant age and sex bias (39). However, the present study
does not confirm the above hypothesis since in both
younger and older groups, compared with the ‘physiolo-
gical definition’, the ‘operational definition’ gives statisti-
cally significant lower percentages of subjects having OVD,
respectively, 9.59% vs. 5.44% and 26.64% vs. 25.28%.
The use of a fixed threshold value for OVD diagnosis is
based on the same reasoning for the diagnosis of other
chronic diseases, such as diabetes or hypertension where
it is conventional that using fixed cut points works well
(72), so that a fixed threshold for FEV1/FVC should work
equally well (76). However, the normal levels of blood
pressures and glycaemia are maintained within a narrow
range of the target value by physiological regulation
systems. There is no such system that controls the level of
FEV1/FVC and the absence of such a target value for
FEV1/FVC should therefore be accepted (72).
Physiological definition
Interpretation of spirometry data is usually based on com-
parisons of parameters measured in an individual patient
or subject with reference values based on healthy subjects
(77). Values below the LLN, defined by the 95% con-
fidence interval, are considered as abnormal (5, 54, 77).
The use of the LLN is an appropriate method to interpret
spirometry data, since the clinical question is whether the
calculated FEV1/FVC ratio is reduced (5, 41, 54). Pro-
blems arise, however, when FEV1/FVC lie near its LLN
(5, 77). In this case, a literal interpretation of the func-
tional defect is too simplistic and could fail to properly
describe the functional status and other tests, such as
the reversibility one, should be performed (5, 77). The
‘operational definition’, compared with the ‘physiological
definition’, underestimated the OVD in 122 subjects (2.6%)
(Table 1). The profile of subjects ‘physio (), operat ()’
is characterised by the predominance of females and non-
smokers; the middle age of included subjects; and higher
FEV1, FVC, and FEV1/FVC (Group III, Table 2).
One limitation to the application of the ‘physiological
definition’ could be a lack of reference values for many
countries, especially the low-income ones, such as some
African countries (5). A Medline search performed on
12 September 2015 and applying the following keywords
(‘reference equations’ and ‘spirometry’ and ‘Africa’ and
‘adult’), found 15 papers with norms published for only a
few African countries (Tunisia, Algeria, South Africa, Sudan,
Rwanda, Togo, Tanzania, Senegal, Ethiopia, and Ivory
Coast). Another limitation is that errors in interpretation
(with respect to both overestimation and underestimation
How to define obstructive ventilatory defect?
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of ventilatory defects) can occur if inappropriate reference
equations are used (20, 26). In Europe and some other
countries, the GLI reference equations are presently recom-
mended (45). These reference equations have been expanded
to include preschool children, and the LLN has been more
precisely defined, using z-scores (45). Similar analyses are
underway to update the spirometry reference equations
for use in Africa with, for example, the project ‘Paediatric
and Adult African Spirometry (PAAS)’ working group.
Implications for research
As advised by the ATS/ERS (5, 17), there is a need
for more research related to OVD definition. Specifically,
there is a need for higher quality prospective studies that
could more clearly identify an unambiguous consensus on
what constitutes an OVD taking account of the smoking
status of subjects.
In conclusion, the prevalence of OVD very much
depends on the criteria used for its definition. The present
study provides powerful support for the view that the
‘physiological definition’ should be applied in order to
avoid the risk of misdiagnosing a part of the population as
free from pulmonary disease. The reasons of simplicity
and ease of remembrance, advanced for the ‘operational
definition’ seem unimportant compared with the objec-
tive of being able to properly detect OVD, especially in
smokers (47). An OVD definition based on LLN derived
from an appropriate spirometric reference equation would
diminish the rate of misinterpretations. It will bring pul-
monary medicine more in line with other medical disci-
plines and facilitate the correct interpretation of spirometry
defects (49). Schooling societies and scientific organisations,
such as GOLD (www.goldcopd.com/, accessed 12 September
2015), are recommended to return to evidence-based medi-
cine and revise their guidelines.
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